Can ductal carcinoma in situ cause breast cancer?

DCIS consists of abnormal cells contained inside a breast milk duct. It becomes invasive when cells cross the duct boundary and enter surrounding breast tissue.

DCIS is a non-invasive breast condition, although some clinicians and reports describe it as an early or in-situ breast cancer. The key distinction is that the abnormal cells have not entered nearby breast tissue and cannot spread elsewhere while they remain confined to the duct.

A biopsy confirms the diagnosis. The pathology report describes features such as grade, extent and hormone-receptor status, which help the breast team estimate how the area may behave and choose treatment. Current tests cannot predict with certainty which individual area of untreated DCIS would become invasive.

Review the imaging and biopsy results with a breast specialist. Treatment commonly starts with surgery to remove the affected area; the choice between breast-conserving surgery and mastectomy depends on its extent, position, breast size, whether there are separate areas and your preferences.

Radiotherapy may be recommended after breast-conserving surgery to reduce the chance of DCIS or invasive cancer returning in that breast. If the cells have hormone receptors, endocrine medicine may also be discussed. Ask how each option changes the expected benefit, side effects and follow-up in your particular case.

Contact a healthcare professional promptly about a new breast or underarm lump, bloody nipple discharge, nipple inversion, skin dimpling, persistent redness or a change in breast shape. Such changes can have non-cancerous causes, but they still need assessment.

A DCIS diagnosis itself is generally managed through planned specialist care rather than an emergency department. During recovery from a biopsy or operation, seek urgent advice for rapidly increasing swelling, heavy bleeding, fever, spreading redness, worsening wound pain, chest pain or difficulty breathing.

Ask whether the biopsy shows DCIS alone, what its grade and extent are, and whether hormone receptors were found. Clarify the recommended operation, whether radiotherapy or endocrine medicine may help, what the final surgical pathology could change, and how follow-up imaging will be arranged.